MediWound Ltd. (MDWD) stock
MDWDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$13.55+0.65 (+5.04%)
Close on Nov 16, 2026Market cap $173.92MP/E –Yield –
MediWound price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
MediWound's price to sales ratio was 10.7× on Nov 10, 2026, against 11.4× a year earlier. Over the last 5 years it ranged from 1.9× to 11.7×, with a median of 8.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 10, 2026 | 10.7× | −1.0 |
| 2025 | Dec 31, 2025 | 11.7× | +2.9 |
| 2024 | Dec 31, 2024 | 8.8× | +5.3 |
| 2023 | Dec 29, 2023 | 3.5× | +0.8 |
| 2022 | Dec 30, 2022 | 2.7× | −0.3 |
| 2021 | Dec 31, 2021 | 3.0× | −0.2 |
| 2020 | Dec 31, 2020 | 3.2× | −21.6 |
| 2019 | Dec 31, 2019 | 24.8× | −19.4 |
| 2018 | Dec 31, 2018 | 44.2× | −18.5 |
| 2017 | Dec 29, 2017 | 62.7× | −102.8 |
| 2016 | Dec 30, 2016 | 165.5× | – |
See a number that looks wrong?